Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EMMA International is a private life sciences consulting company that provides regulatory, quality, compliance, operational, and commercialization support to pharmaceutical, biotechnology, medical device, diagnostics, and combination product organizations. The company positions itself as an integrated consulting and turnkey solutions provider, helping clients with FDA and other global regulatory submissions, quality systems, audits, CAPA, process optimization, and market readiness. Its services are aimed at clients ranging from early-stage biotech companies to global pharmaceutical operations rather than at developing its own therapeutic pipeline. EMMA International also markets digital and AI-enabled support services for life sciences workflows. Overall, it appears to function as a commercial-stage consulting and services partner to regulated healthcare and life sciences companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EMMA International.